NIDA National Drug Abuse Treatment Clinical Trials Network (CA-AZ Node)

UCSF leads the California-Arizona Research Node of the NIDA National Drug Abuse Treatment Clinical Trials Network (CTN). The overall goal of the Research Node is to participate in and conduct high-quality multi-site clinical trials of interventions for drug abuse and addiction, and to guide the development, dissemination, and adoption of effective interventions in the field.  The Research Node consists of a Regional Research and Training Center (RRTC) at UCSF that is linked in partnership with researchers at the University of Arizona and with twenty community-based treatment programs (CTPs) in California and Arizona.  The goal of the CA-AZ Research Node is to stimulate research to improve the effectiveness of treatment of addiction to opiates, cocaine and methamphetamine, nicotine, and other abused drugs. The gap between research and treatment is one of the most critical unresolved issues in drug abuse. The Node fosters collaboration among scientists and practitioners to stimulate new research improving the effectiveness of drug abuse treatment in community settings.

UCSF Investigators

• James L. Sorensen, PhD, PI & Director
• Joseph R. Guydish, PhD, Co-PI & Co-Director 
• Carmen Masson, PhD, Training & Quality Assurance
• Steve Batki, MD  
• Grant Colfax, MD, MPH
• Janice Tsoh, PhD
• Elinore McCance-Katz, MD, PhD

University of Arizona Investigators

• Varda Shoham, PhD, PI, University of Arizona
• Michale Rohrbaugh, PhD, Co-PI, University of Arizona

Key Staff

• Audrey Brooks, PhD, Training & Quality Assurance
• Tim Matheson
• Anh Nguyen, BA, Research Administrative Coordinator
• Barbara Paschke, MEd, Node Coordinator
• Michael Shopshire, PhD, Training & Quality Assurance
• Adrienne Wente, BA, Assistant to Director

Community Treatment Programs (CTPs)

• Bi-Valley Medical Clinic, Inc.,Sacramento, CA, Executive Director: John J. McCarthy, MD
• East Bay Community Recovery Project, Oakland, CA, Executive Director:Joan Zweben,PhD
• La Frontera Center, Inc.,Tucson, AZ, Site PI: Patricia Penn, PhD 
• San Francisco General Hospital Division of Substance Abuse and Addiction Medicine(DSAAM), SitePI:Valerie Gruber, PhD

Allied Programs

• Native American Health Center,Oakland, CA, Site Leader: Ethan Nebelkopf PhD
• San Francisco Veterans Affairs Medical Center, Site Leader:Peter Banys, MD
• Tohono O’odham Nation, Sells, AZ, Site Leader: Juanita Homer
• Walden House, San Francisco, CA, Site Leader: Richard Jimenez

Implementation Partners

• Alameda County Behavioral Health Care Services, Director: Marye L. Thomas, MD
• Asian Pacific Islanders Wellness Center, Executive Director: Lance Toma, LCSW
• California Society of Addiction Medicine, Director:Peter Banys, MD, MSc
• Community Partnership of Southern Arizona, Director of Research and System Development:Michael R. Berren, PhD
• Contra Costa County Alcohol & Other Services, Director: Haven Fearn
• Marin County Division of Alcohol, Drug & Other Tobacco Programs, Chief: D.J. Pierce
• Monterey County Behavioral Health, Behavioral Health Director: Wayne Clark, PhD
• Pacific Southwest Addiction Technology Transfer Center, Director: Thomas E. Freese, PhD
• Richmond Area Multi Services, President & CEO: Kavoos G. Bassiri, LMFT, CGP
• San Francisco Community Behavioral Health Services, Director: Robert Paul Cabaj, MD
• San Mateo County Substance Abuse & Shelter Services, AOD Administrator: Judy Davila
• Sonoma County Alcohol & Other Drug Services Division, Director: Gino Giannavola, MPA

Contact

James L. Sorensen, PhD, Principal Investigator Director of the California-Arizona CTN Node
University of California, San Francisco
San Francisco General Hospital
1001 Potrero Avenue
Building 20, Suite 2117, Box 0852
San Francisco, CA 94110
415-206-3969